Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Comment by CaptainCrunchyon Sep 03, 2021 5:21pm
73 Views
Post# 33813369

RE:RE:RE:RE:RE:RE:RE:Webinar

RE:RE:RE:RE:RE:RE:RE:Webinar
ya seriously. That is not the problem to handle tabletz for sure. It sounded like tabletz is finalizing roll out plan. Covid slowed supply chain everywhere (maybe those 46k locations are running behind trying to adapt to covid conditions) Shipping, never sounded like issue before, this makes me think the initial is ready to go and working that out. Really, it sounds like the delay on this order is a temporary macro issue and probably shipping soon future orders will not have the same hurdles. Crypharm is still alive, and ya it sounded good that some revenues will be on next financials. I can't imagine those will be anything like tabletz, but, take everything we can get and that partner still working on growing also. Seems like we may be about to pass the first massive hurdle, get initial out and the issues with this one will likely not be issue for future orders. No doubt we can pump out everything they ask for and once covid and shipping stop being and issue, the roll out is complete and it becomes simply restocking. Money should roll in at a pretty consistent pace.
<< Previous
Bullboard Posts
Next >>